SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas

Clin Lymphoma Myeloma Leuk. 2022 May;22(5):287-296. doi: 10.1016/j.clml.2021.10.006. Epub 2021 Oct 15.

Abstract

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous and often clinically aggressive group of neoplasms derived from mature post-thymic T-lymphocytes. These neoplasms are rare and usually diagnostically challenging. Our understanding of the pathogenesis of PTCL is increasing and this improved knowledge is leading us to better molecular characterization, more objective and accurate diagnostic criteria, more effective risk assessment, and potentially better treatments. The focus of this paper is to present a brief overview of the current pathology criteria and molecular and genetic features of nodal peripheral T-cell lymphomas focusing on distinct genetically and molecularly defined subgroups that are being recognized within each major nodal PTCL category. It is expected that the molecular stratification will improve the diagnosis and will provide novel therapeutic opportunities (biomarker-driven and targeted therapies) that might benefit and change the outcomes of patients with these neoplasms.

Keywords: Anaplastic large cell lymphoma; Angioimmunoblastic T-cell lymphoma; Follicular T-helper; NOS; Peripheral T-cell lymphoma.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Lymphoma, T-Cell, Peripheral* / etiology
  • Lymphoma, T-Cell, Peripheral* / genetics
  • T-Lymphocytes

Substances

  • Biomarkers